Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Insulin Resistance 1Hyperandrogenism 1Glucose Intolerance 1Endometrial Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Anovulation 1Anastomotic Leak 1Adenomatous Polyposis Coli 1

Interventions

Metformin 10Clomiphene 10Inositol 3Medroxyprogesterone Acetate 2Letrozole 2Glycoprotein Hormones, alpha Subunit 2Folic Acid 2Chorionic Gonadotropin 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Lactalbumin 1Inulin 1Flutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anovulation × Inulin × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡